Current report No. 8\/2022
Date prepared: 2022-04-15
Abbreviated name of the issuer: CELON PHARMA S.A.
Subject: Allocation of A series subscription warranties to eligible persons under the Incentive Program for persons of key importance to the Company
Legal basis: Article 17 section 1 of the Market Abuse Regulation (MAR) \u2013 inside information.
Content of the report:
The Management Board of Celon Pharma S.A. (the \u201cCompany\u201d) hereby informs that on April 15, 2022 the Company assigned 5,000 A series subscription warrants (\u201cWarrants\u201d) in total to the eligible persons who had made relevant subscriptions; each Warrant entitles them to subscribe for 1 C series share of the Company at the issue price of PLN 0.10 per share.
The Warrants are issued on the basis of Resolution No. 7\/2021 of the Extraordinary General Meeting of the Company of February 16, 2021 on the issue, for the purpose of implementing Incentive Programs for Members of the Management Board and other persons of key importance to the Company, of A series subscription warrants with exclusion of share subscription rights of existing shareholders, entitling them to subscribe for C series shares and a conditional increase of the share capital through the issue of C series shares with exclusion of share subscription rights of existing shareholders and an amendment to the Company’s Articles of Association related thereto.
Their allocation was made on the basis of Resolution No. 6 adopted by the Extraordinary General Meeting of the Company of February 16, 2030 on the introduction of Incentive Programs for Members of the Management Board and other persons of key importance to the Company and on the basis of the regulations of the Incentive Program for Company\u2019s Officers for the years 2021-2030 in Celon Pharma S.A. (see current report No. 44\/2021), in connection with the approval by the Management Board of the Company of eligible persons fulfilling a part of the objectives set in accordance with the provisions of these regulations.
This decision of the Management Board of the Company is the second decision regarding the allocation of A series subscription warrants for 2021 under the Incentive Program for Company\u2019s Officers. The Company informed of the first allocation of A series subscription warrants for 2021 in the current report no. 45\/2021 of November 2, 2021.<\/p>\n","protected":false},"excerpt":{"rendered":"